Tigulixostat lowers uric acid levels

Published On 2021-12-09 11:27 GMT   |   Update On 2021-12-15 05:54 GMT

Tigulixostat significantly lowers the levels of serum uric acid (sUA) in gout patients with hyperuricemia versus placebo at all dose levels, according to results from a phase 2, dose-finding study. Also, the sUA lowering effect of tigulixostat appeared to be dose-dependent. Study participants tolerated well to the treatment with tigulixostat at all 3 dose levels.

The study was presented as the late-breaking posters at the ACR (American College of Rheumatology) Convergence 2021.

Advertisement

For more details, check out the full story on the link below: 

Tigulixostat Lowers Uric Acid Levels In Gout Patients With Hyperuricemia: Study





Full View
Tags:    

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News